コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 y of an isolate allows for strain typing and antimicrobial susceptibility testing).
2 sm identification and automated-system-based antimicrobial susceptibility testing.
3 nating the need for biochemical analysis and antimicrobial susceptibility testing.
4 ime needed for phenotypic identification and antimicrobial susceptibility testing.
5 gel electrophoresis (PFGE), serotyping, and antimicrobial susceptibility testing.
6 quence typing (MLST), plasmid profiling, and antimicrobial susceptibility testing.
7 nce of accurate organism identification, and antimicrobial susceptibility testing.
8 ted by the NCCLS Subcommittee for Veterinary Antimicrobial Susceptibility Testing.
9 tion's External Quality Assurance System for Antimicrobial Susceptibility Testing.
10 bolic profiling provides an avenue for rapid antimicrobial susceptibility testing.
11 phoresis, extended virulence genotyping, and antimicrobial susceptibility testing.
12 demonstrated an added value for LC-MS/MS in antimicrobial susceptibility testing.
13 ria promulgated by the European Committee on Antimicrobial Susceptibility Testing.
14 for broad-based bacterial identification or antimicrobial susceptibility testing.
15 Antimicrobial susceptibility testing.
16 t bacilli smears, and microbial cultures and antimicrobial susceptibility testing.
18 Typhi strains has emerged worldwide, making antimicrobial susceptibility testing an important functi
19 s of 2004 to 2005 and 2009 to 2010 underwent antimicrobial susceptibility testing and characterizatio
20 pulsed-field gel electrophoresis (PFGE) and antimicrobial susceptibility testing and examined for th
21 ne can expect to see changes in guidance for antimicrobial susceptibility testing and interpretation.
25 istance mechanisms in staphylococci, current antimicrobial susceptibility testing and reporting recom
28 ion between the results of existing in vitro antimicrobial susceptibility tests and clinical outcome
29 ovides an effective quantitative measure for antimicrobial susceptibility testing, and determination
30 e now using WGS for pathogen identification, antimicrobial susceptibility testing, and epidemiologica
31 by the VITEK 2 system for identification and antimicrobial susceptibility testing, and the results we
32 In January 2015, the CLSI Subcommittee on Antimicrobial Susceptibility Testing approved these rang
33 which were outside of the United States, for antimicrobial susceptibility testing as part of the Worl
34 Our results suggest that a rapid and robust antimicrobial susceptibility test (AST) can be construct
35 icular, the absence of FDA-cleared automated antimicrobial susceptibility test (AST) devices that use
44 oenix system for the identification (ID) and antimicrobial susceptibility testing (AST) of 251 isolat
45 Sparks, MD) for the identification (ID) and antimicrobial susceptibility testing (AST) of challenge
47 signed for the rapid identification (ID) and antimicrobial susceptibility testing (AST) of clinically
50 rovide rapid species identification (ID) and antimicrobial susceptibility testing (AST) results for t
52 ast majority of bacterial identification and antimicrobial susceptibility testing (AST) results were
53 boring MRSA, including three (semi)automated antimicrobial susceptibility testing (AST) systems and f
54 sistant Klebsiella pneumoniae demands faster antimicrobial susceptibility testing (AST) to guide anti
55 atory practice in the preanalytical phase of antimicrobial susceptibility testing (AST) was evaluated
56 determining the optimal frequency of repeat antimicrobial susceptibility testing (AST) when an organ
59 ISA (hVISA) are pathogens for which accurate antimicrobial susceptibility testing (AST) would rule ou
60 harmacokinetics (PK), pharmacodynamics (PD), antimicrobial susceptibility testing (AST), and how thes
62 n and facilitates rapid bacterial growth for antimicrobial susceptibility testing at the point of car
63 large surface-to-volume ratio, toward rapid antimicrobial susceptibility testing at the point of car
64 dy were approved by the CLSI Subcommittee on Antimicrobial Susceptibility Testing at their June 2015
65 simple microfluidic device that can perform antimicrobial susceptibility testing automatically via a
67 through 10 May 2016 underwent routine Etest antimicrobial susceptibility testing by the Hawaii Depar
68 enotypic analysis, including biochemical and antimicrobial susceptibility testing, cellular fatty aci
69 em, were determined by the dielectrophoretic antimicrobial susceptibility testing (dAST) and by the c
70 ical clustering results for MS, genomic, and antimicrobial susceptibility test data to hierarchical c
72 or =1 microg/ml by the European Committee on Antimicrobial Susceptibility Testing]; disk diffusion br
73 tion's External Quality Assurance System for Antimicrobial Susceptibility Testing (EQAS-AST) from Jan
74 s Institute (CLSI) and European Committee on Antimicrobial Susceptibility Testing (EUCAST) broth micr
75 s Institute (CLSI) and European Committee of Antimicrobial Susceptibility Testing (EUCAST) methodolog
76 k breakpoints, and the European Committee on Antimicrobial Susceptibility Testing (EUCAST) S. pseudin
77 on (BMD) method of the European Committee on Antimicrobial Susceptibility Testing (EUCAST) was compar
81 ew method developed and evaluated as a rapid antimicrobial susceptibility test for B. anthracis This
82 enterococci following a laboratory change in antimicrobial susceptibility testing from disk diffusion
84 ofluidic device provides a simple method for antimicrobial susceptibility testing in an automated for
85 ds were approved by the CLSI Subcommittee on Antimicrobial Susceptibility Testing in January 2015 and
86 terobacteriaceae family poses a challenge to antimicrobial susceptibility testing in the clinical lab
88 tandards Institute and European Committee on Antimicrobial Susceptibility Testing interpretative stan
93 f identification to bacterial species level, antimicrobial susceptibility testing, macrolide resistan
94 atory Standards Institute (CLSI) revised the antimicrobial susceptibility testing method for telavanc
95 should consider using a second, independent antimicrobial susceptibility testing method to validate
99 up organisms on the selection of appropriate antimicrobial susceptibility testing methods and interpr
103 me geographic area using broth microdilution antimicrobial susceptibility testing, multilocus sequenc
106 uld be developed, and the optimal method for antimicrobial susceptibility testing of A. xylosoxidans
109 tion and the agar disk diffusion methods for antimicrobial susceptibility testing of Campylobacter we
111 as been used to reduce the time required for antimicrobial susceptibility testing of Mycobacterium tu
112 s for the performance and quality control of antimicrobial susceptibility testing of Mycoplasma pneum
113 methods decrease the time to identification/antimicrobial susceptibility testing of S. aureus and de
114 ods take several days for identification and antimicrobial susceptibility testing of staphylococcal i
115 It appears to be an acceptable method for antimicrobial susceptibility testing of staphylococci an
116 in S. aureus, Vitek 2 performed reliably for antimicrobial susceptibility testing of staphylococci an
118 control limits and interpretive criteria for antimicrobial susceptibility testing of Streptococcus pn
121 lity control (QC) standards for the in vitro antimicrobial susceptibility testing of two fastidious v
124 A bloodstream isolates were characterized by antimicrobial susceptibility testing, PCR analysis of vi
126 e isolates were characterized by serotyping, antimicrobial-susceptibility testing, phage typing, and
128 ble S. aureus isolates were characterized by antimicrobial-susceptibility testing, pulsed-field gel e
130 ysis interpretation, culture thresholds, and antimicrobial susceptibility testing, require special co
131 ) CD-ROM on AST, and (iv) the CDC Multilevel Antimicrobial Susceptibility Testing Resource website.
133 cultures, and BD Phoenix identification and antimicrobial susceptibility test results were comparabl
134 high degree of correlation of serotyping and antimicrobial susceptibility testing results between fou
135 increased the importance of having accurate antimicrobial susceptibility testing results for guiding
137 NS category, the organism identification and antimicrobial-susceptibility test results should be conf
139 tant but clindamycin susceptible by in vitro antimicrobial susceptibility testing should be tested fo
140 ified selection for changes in motility, and antimicrobial susceptibility testing suggested that the
141 ed in conjunction with the VITEK 2 automated antimicrobial susceptibility test system to ascertain th
144 pid quantitative PCR (qPCR)-based phenotypic antimicrobial susceptibility test that utilizes amplific
146 apid ID 32 Strep identification methods, and antimicrobial susceptibility testing to determine their
147 , relevant interpretations of the results of antimicrobial susceptibility tests to clinicians, clinic
148 esis (PFGE) following SmaI macrorestriction, antimicrobial susceptibility testing, urease production,
149 human clinical specimens, were subjected to antimicrobial susceptibility testing using a MicroScan W
150 We present a method for rapid and scalable antimicrobial susceptibility testing using stationary na
152 lobacter spp. and E. coli were isolated, and antimicrobial susceptibility testing was conducted using
158 ngoing national surveillance, serotyping and antimicrobial susceptibility testing were done on all pn
159 culture, manual speciation, serotyping, and antimicrobial susceptibility testing were performed at M
161 apid ID 32 Strep identification methods; and antimicrobial susceptibility testing were performed on t
162 Culture-based identification methods and antimicrobial susceptibility testing were used as the re
165 i clinical strain WCHEC13-8 was subjected to antimicrobial susceptibility tests, whole genome sequenc
166 od, Mo.), an established automated method of antimicrobial susceptibility testing with the ability to
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。